Literature DB >> 104988

Studies on human kininogens. I. Isolation, characterization, and cleavage by plasma kallikrein of high molecular weight (HMW)-kininogen.

T Nakayasu, S Nagasawa.   

Abstract

1. Human high molecular weight (HMW)-kininogen was highly purified from human plasma by chromatographies on QAE-Sephadex A-50 and CM-Sephadex C-50. Human HMW-kininogen thus purified was a mixture of a single chain and a disulfide-linked pair of chains. Human HMW-kininogen is an acidic glycoprotein having a molecular weight of 120,000. The amino acid composition of human HMW-kininogen is quite similar to that of bovine HMW-kininogen. 2. We investigated whether the liberation of kinin from human HMW-kininogen by human plasma kallikrein was accompanied by liberation of histidine-rich fragments, as observed with bovine HMW-kininogen (Han et al. (1975) J. Biochem. 77, 55--68). After prolonged incubation of human HMW-kininogen and human plasma kallikrein followed by gel-filtration on Sephadex G-50, a fragment of molecular weight 8,000 was isolated together with bradykinin. However, the histidine content of the fragment was not as high as that in the bovine fragments. Most of the histidine in human HMW-kininogen was recovered in the kinin-free protein, and the light chain of kinin-free protein was found to be rich in histidine compared with the heavy chain. These results suggest that the histidine-rich sequence in human HMW-kininogen is not released by the action of human plasma kallikrein, but remains bound to the light chain of kinin-free protein.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 104988     DOI: 10.1093/oxfordjournals.jbchem.a132318

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  8 in total

1.  Inhibition of prekallikrein activation in human plasma by components of bovine plasma.

Authors:  K M Weerasinghe; E P Kirby
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

Review 2.  FXII.

Authors:  G Fuhrer; M J Gallimore; W Heller; H E Hoffmeister
Journal:  Blut       Date:  1990-11

3.  Regulation of factor XIa activity by platelets and alpha 1-protease inhibitor.

Authors:  P N Walsh; D Sinha; F Kueppers; F S Seaman; K B Blankstein
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

4.  Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain.

Authors:  R E Thompson; R Mandle; A P Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

5.  Ferritin binds to light chain of human H-kininogen and inhibits kallikrein-mediated bradykinin release.

Authors:  Narayanan Parthasarathy; Suzy V Torti; Frank M Torti
Journal:  Biochem J       Date:  2002-07-01       Impact factor: 3.857

6.  The kinetics of hydrolysis of some extended N-aminoacyl-L-arginine methyl esters by human plasma kallikrein. Evidence for subsites S2 and S3.

Authors:  P R Levison; G Tomalin
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

7.  Prekallikrein activation in human, bovine, and rabbit plasmas: presence of an inhibitor in bovine plasma.

Authors:  K M Weerasinghe
Journal:  Inflammation       Date:  1992-06       Impact factor: 4.092

Review 8.  Modulation of the Plasma Kallikrein-Kinin System Proteins Performed by Heparan Sulfate Proteoglycans.

Authors:  Guacyara Motta; Ivarne L S Tersariol
Journal:  Front Physiol       Date:  2017-07-11       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.